Medstar Georgetown-Lombardi Comprehensive Cancer Center

Washington D.C., District of Columbia 20007

0 studies enrolling now · 1 studies all time

What they study most

Malignant Melanoma

Studies at this site

• Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma — Completed